U.S. P2Y12 INHIBITORS MARKET ANALYSIS

U.S. P2Y12 Inhibitors Market, by Drug (Clopidogrel, Ticlopidine, Ticagrelor, Prasugrel, Cangrelor, and Others), by Route of Administration (Oral and Intravenous), by Application (Angioplasty, Arterial Thrombosis, Percutaneous Coronary Interventions, Myocardial Infarction, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI4983
Pages :156
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Potential side effects of drugs

U.S. P2Y12 Inhibitors Market: Restraint

The major factors that may hinder growth of the U.S. P2Y12 inhibitors market include potential side effects of drugs. For instance, side effects of P2Y12 inhibitors include diarrhea, itching, nausea, skin rash, and stomach pain. Moreover, ticlopidine may lead to a very low white blood cell count or an immune disorder that destroys platelets. Ticagrelor may cause episodes of shortness of breath.

U.S. P2Y12 Inhibitors Market Report Snapshots